Veterinary Medicines: Northern Ireland

Gavin Robinson Excerpts

Wednesday 3rd December 2025 Westminster Hall

[Robin Swann]

I agree with the hon. Member. It is not just the politicians who are saying that: the British Veterinary Association has said:

“From 1 January 2026, the supply of veterinary medicines in Northern Ireland will be thrown into uncertainty on account of the end of a post-Brexit grace period. The issue of veterinary medicines was not sufficiently addressed in the Windsor Framework, and in the absence of a veterinary agreement between the UK and the EU, the supply of critical products like vaccines for production animals, companion animals and horses, cannot be guaranteed.”

In June 2025, the Government announced the veterinary medicine health situation scheme, which was meant to permit the use of suitable alternative products from outside Northern Ireland through exemptions but, with only weeks to go, the definition of exemption is still unclear. It was also announced that the veterinary medicines internal market scheme will enable vets to use, when needed, specific individual medicines that are not authorised or available in Northern Ireland. Again, the process for accessing those is still unclear.

It has been reported that between 10% and 15% of drugs and pack sizes are expected to be discontinued in Northern Ireland, and we know that 20 of those have no suitable alternative available on the Northern Ireland market. If manufacturers find it unviable to continue supplying Northern Ireland, vets, farmers and pet owners will be left with far fewer options.

Ministers have informed me that they are working with four online retailers to ensure a continued supply of veterinary medicines in the new year. Animal owners with a prescription from a vet will be able to order medicines through one of those sites, but there is still no clarification as to who will be able to order and when—or even which medicines will be available—through what is, for many, a way of accessing affordable veterinary medicines.

It is important to note that, even if any of the four retailers comes online, not all drugs currently used by animal owners may be available. In some cases, alternatives or substitutes will need to be found, sometimes at very short notice, and unfortunately substitutes are not a fix-all solution. Allergies, intolerances and other sensitivities mean that some animals will not be able to use those alternatives. That highlights the ongoing risks and the need for a long-term solution.

Marketing authorisation for a product does not necessarily mean that it will continue to be supplied. Indeed, manufacturers are still finalising their decisions, which they may or may not communicate in advance of January. Northern Ireland farmers are already under pressure from the threat of disease, rising costs and the introduction of the farm family inheritance tax. Losing access to essential veterinary medicines would make it far harder to maintain healthy livestock and sustainable family businesses. Not only will pet owners feel the impact, with everyday treatments potentially becoming scarce or expensive, but animal rescue charities, which already operate on tight budgets, fear that the disruption could prevent them from providing for the animals in their care.

As a former Health Minister, I know that any threat to animal health is also a threat to human health. Effective disease control in animals underpins food safety, public health and the security of our agrifood sector, and antimicrobial resistance is a real threat to both humans and animals.

[Gavin Robinson (Belfast East) (DUP)]

I congratulate the hon. Member on securing the debate. He is right to invoke the issue of human health, because it was the European Union that went as far as to invoke article 16 to frustrate the supply of covid vaccines in Northern Ireland, before it realised that doing so was politically inappropriate. On this issue, the EU wishes to prioritise its single market, but the fundamental failure is that our Government are not prepared to stand up and ensure the protection of our single market. The European Union will talk about food chain supplies, but when it comes to domestic animals, I have young owners coming to me now complaining about the lack of availability of online supplies for their dog. Can we have a recognition that there are a lot of domestic animals that receive online veterinary medicines that will never enter the supply chain—and that it would be illegal if they did?

--- Later in debate ---

[The Parliamentary Under-Secretary of State for Environment, Food and Rural Affairs (Emma Hardy)]

It is such a pleasure to serve under your chairwomanship, Dr Allin-Khan, and to respond to the debate. I thank the hon. Member for South Antrim (Robin Swann) for securing this debate on a highly important matter and for his continued commitment to the veterinary medicine supply in Northern Ireland. He might have noticed I am not the farming Minister, but I am pleased to be here to respond on her behalf.

I recognise how important this issue is to the people of Northern Ireland and all the communities the hon. Gentleman represents. He has raised many important issues with me today; I will endeavour to address as many as possible. Baroness Hayman was in Northern Ireland just last week meeting the hon. Gentleman and many of our organisations. She met vets, the Minister of Agriculture, Environment and Rural Affairs, the permanent secretary, and the Northern Ireland Business Brexit Working Group to demonstrate how important the issue is to the UK Government. Those channels of dialogue remain open.

I thank industry stakeholders for their ongoing support and work to make the changes necessary to continue supply to Northern Ireland. We have done extensive work with industry, which has given us the confidence in the arrangements we have put in place to manage a smooth transition into 2026. Before responding to specific questions raised in the debate, I want first to outline the Government’s view on veterinary medicine in Northern Ireland.

Safeguarding the supply of veterinary medicine in Northern Ireland after the grace period ends remains a core Government priority. We are committed to ensuring that the health and welfare of all animals is maintained in all circumstances. We are aware of concerns raised about pack size, discontinued products and the potential for increased costs, and we take those concerns extremely seriously. We have engaged extensively with stakeholders on those issues. Based on the evidence available to us through this engagement, our view remains that disruption at the end of the grace period will be limited and the arrangements we have in place will manage supply into 2026.

[Gavin Robinson]

I am grateful to the Minister for taking the intervention. Does she accept that the fundamental flaw in the Government’s approach is to accept the premise that the European Union controls what access there should be from one part of our United Kingdom to another and that we are accepting that there should be a chink in the UK internal market? Does she understand that when the grace period comes to an end, the European Union cannot and will not be able to demonstrate any detriment to their single market because of the ongoing availability until the end of this year. There has not been any detriment to their single market because of the availability of veterinary medicines from GB to Northern Ireland; and nor will there be, so all this is wholly disproportionate and unnecessary.

[Emma Hardy]

I thank the right hon. Member. He will recognise that it is important for the UK to be legally compliant with all of our international agreements. We take seriously the Windsor framework and the rules that it gave our country. I would not want to be part of a Government who disregard international agreements, but I completely understand his concerns around veterinary medicines.

We expect 10% to 15% of currently licensed veterinary medicines in Northern Ireland to be discontinued, but most are either dormant and not sold in Northern Ireland or have multiple alternatives available. We have analysed each discontinuation against multiple criteria to determine the position. However, we appreciate we can never have perfect data and that situations change. That is why we have also announced the veterinary medicines internal market scheme and the veterinary medicine health situation scheme: to help to address any gaps, should they arise.

The veterinary medicines internal market scheme removes administrative burdens from vets moving medicine that are not vaccines from Great Britain to Northern Ireland when, in their clinical judgment, that is needed. It is based on the existing cascade procedure, with which vets are very familiar. These simplifications allow the scheme to be as responsible as possible when managing supply issues.

The veterinary medicine health situation scheme allows the Government to temporarily authorise an alternative medicine when a discontinuation is expected to lead to a health situation. It is designed to provide a dedicated supply mechanism to address supply issues, should they arise.